Lysoway Therapeutics vs Quince Therapeutics
Lysoway Therapeutics vs Quince Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Lysoway Therapeutics is on 48/100 and Quince Therapeutics on 37/100.
Where each one leads
Lysoway Therapeutics
- our overall score: 48/100 against 37/100
Quince Therapeutics
- funding raised: $63.0M against $45.0M
At a glance
| Measure | Lysoway Therapeutics | Quince Therapeutics |
|---|---|---|
| What it is | Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases. | A biopharmaceutical company focused on developing novel therapies. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience | Biotechnology, Pharmaceuticals, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2021 | 2020 |
| Headquarters | Cambridge, USA | South San Francisco, USA |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Lysoway Therapeutics | Quince Therapeutics |
|---|---|---|
| Total funding | $45.0M | $63.0M |
| Latest round | Series A | Series C |
| Valuation | $1.1B | $1.1B |
| LinkedIn followers | 1,282 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Lysoway Therapeutics | Quince Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 37/100 |
| Traction | 38/100 | 39/100 |
| Community | 15/100 | Not published |
| Search visibility | 20/100 | 13/100 |
| Quality | 68/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (39/100) |
| Domain ratingLink authority, 0-100 | Not published | 38/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Lysoway Therapeutics | Quince Therapeutics |
|---|---|---|
| Hosting | Not detected | AWS |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Jetpack Stats |
Lysoway Therapeutics vs Quince Therapeutics: common questions
Which is better, Lysoway Therapeutics or Quince Therapeutics?
On our 0-100 score Lysoway Therapeutics rates higher (48/100 against 37/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Lysoway Therapeutics and Quince Therapeutics compare on the numbers?
Lysoway Therapeutics leads on our overall score (48/100 against 37/100). Quince Therapeutics leads on funding raised ($63.0M against $45.0M).
Read the full Lysoway Therapeutics review and pricing or the Quince Therapeutics review and pricing. You can also browse other Lysoway Therapeutics alternatives we track.